Balanced hydroxyethylstarch (hes 130/0.4) impairs kidney function in-vivo without inflammation

HIGHLIGHTS

  • who: Martin Alexander Schick et al. from the Institute of Anaesthesia and Critical Care, University Hospital Würzburg, Würzburg, Germany have published the paper: Balanced Hydroxyethylstarch (HES 130/0.4) Impairs Kidney Function In-Vivo without Inflammation, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0137247]. September 4, 2015 of April/21,/2015
  • what: To proof the statement, that applying HES for volume resuscitation improves outcome, additional clinical trials and studies, focusing on adverse effects of HES regarding kidney function, are needed.
  • how: The authors conducted an animal study to . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?